Edgewise Therapeutics, Inc. (EWTX) vs Iovance Biotherapeutics, Inc. (IOVA)
Edgewise Therapeutics, Inc. and Iovance Biotherapeutics, Inc. are both Biotechnology companies. Iovance Biotherapeutics, Inc. is the larger, with a market value of $4.9B against $4.4B — 1.1× the size. Edgewise Therapeutics, Inc. has the higher net margin (0.00% vs −89.1%) and the higher return on invested capital (0.00% vs −43.0%). Across the 13 metrics below, Edgewise Therapeutics, Inc. leads on 8 and Iovance Biotherapeutics, Inc. on 5.
Valuation
Profitability
| Metric | EWTX | IOVA | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 48.40% | 65.16% |
| Operating margin | 0.00% | (92.72%) | 0.00% |
| Net margin | 0.00% | (89.09%) | 0.00% |
| Free cash flow margin | 0.00% | (91.21%) | 0.00% |
| Return on equity | (38.03%) | (40.36%) | (57.72%) |
| Return on assets | (36.09%) | (31.76%) | (49.22%) |
| Return on invested capital | 0.00% | (42.96%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack